Basalzellkarzinom: A prospective, open, single-arm, single center, phase II trial to assess the efficacy of anti-PD1 antibody in combination with pulsed Hedgehog inhibitor in advanced Basal Cell Carcinoma

Stadium/Indikation inkl. Kurzinfo

Lymphom / BCC

Fortgeschrittenes BCC (metastasierendes, lokal fortgeschrittenes, nicht resezierbar oder radio-therapeutisch nicht behandelbar, multiple BCC)

Anti-PD1 + Sonidegib

Kurztitel

IIT Pyrexia-Management
NCT04652258

Offizieller Titel

A prospective, open, single-arm, single center, phase II trial to assess the efficacy of anti-PD1 antibody in combination with pulsed Hedgehog inhibitor in advanced Basal Cell Carcinoma